FACTORS INFLUENCING THE ESTABLISHMENT OF TUMOR-INFILTRATING LYMPHOCYTE-CULTURES FROM HUMAN BREAST-CARCINOMA AND COLON-CARCINOMA TISSUE

被引:6
作者
CRANNAGE, KE
ROGERS, K
JACOB, G
STODDARD, CJ
THOMAS, WEG
POTTER, CW
REES, RC
机构
[1] UNIV SHEFFIELD,DEPT SURG,SHEFFIELD S10 2RX,S YORKSHIRE,ENGLAND
[2] HALLAMSHIRE HOSP,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND
关键词
D O I
10.1016/0277-5379(91)90475-S
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumour-infiltrating lymphocytes (TIL) were obtained from breast and colon tumour tissue and cultured in vitro in the presence of recombinant human interleukin-2. Seven of 35 breast tumours and five of 41 colon TIL cultures were established in vitro: proliferation rates of greater than 10(3) were achieved. The cytotoxic capacity of these cells was determined against the cell lines K562 and SW742, and percentage cytotoxicity levels of greater than 97% and 79%, respectively, were seen. An inverse relationship between the ability of TIL to kill and their proliferative capacity was observed in all cultures. The prominent phenotype was CD3 positive, with greater than 55% of TIL expressing this antigen; there was no expression of CD16. The expression of CD56 and CD25 varied, being maximumly expressed on 64% and 38% of TIL, respectively. When greater then 90% of TIL expressed CD3, the ability of the culture to kill the target cell lines was low; only when there was an increase in the proportion of cells expressing CD56 and a decrease in the expression of CD3 was there high cytotoxicity. This study indicates that the TIL which proliferate in vitro in the presence of interleukin-2 are not necessarily the mediators of cytotoxicity.
引用
收藏
页码:149 / 154
页数:6
相关论文
共 29 条
[1]  
BELLDEGRUN A, 1988, CANCER RES, V48, P206
[2]   A NEW REGIMEN OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS - EFFICACY WITHOUT SIGNIFICANT TOXICITY [J].
EBERLEIN, TJ ;
SCHOOF, DD ;
JUNG, SE ;
DAVIDSON, D ;
GRAMOLINI, B ;
MCGRATH, K ;
MASSARO, A ;
WILSON, RE .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (12) :2571-2576
[3]   TUMOR-LOCALIZATION OF ADOPTIVELY TRANSFERRED IN-111 LABELED TUMOR INFILTRATING LYMPHOCYTES IN PATIENTS WITH METASTATIC MELANOMA [J].
FISHER, B ;
PACKARD, BS ;
READ, EJ ;
CARRASQUILLO, JA ;
CARTER, CS ;
TOPALIAN, SL ;
YANG, JC ;
YOLLES, P ;
LARSON, SM ;
ROSENBERG, SA .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (02) :250-261
[4]   METASTATIC RENAL-CANCER TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS - A PHASE-II CLINICAL-TRIAL [J].
FISHER, RI ;
COLTMAN, CA ;
DOROSHOW, JH ;
RAYNER, AA ;
HAWKINS, MJ ;
MIER, JW ;
WIERNIK, P ;
MCMANNIS, JD ;
WEISS, GR ;
MARGOLIN, KA ;
GEMLO, BT ;
HOTH, DF ;
PARKINSON, DR ;
PAIETTA, E .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (04) :518-523
[5]   LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].
GRIMM, EA ;
MAZUMDER, A ;
ZHANG, HZ ;
ROSENBERG, SA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) :1823-1841
[6]  
HEO DS, 1988, J IMMUNOL, V140, P4042
[7]   AUTOLOGOUS TUMOR-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T IN THE INFILTRATE OF HUMAN METASTATIC MELANOMAS - ACTIVATION BY INTERLEUKIN-2 AND AUTOLOGOUS TUMOR-CELLS, AND INVOLVEMENT OF THE T-CELL RECEPTOR [J].
ITOH, K ;
PLATSOUCAS, CD ;
BALCH, CM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (04) :1419-1441
[8]  
KRADIN RL, 1989, LANCET, V1, P577
[9]   FUNCTIONAL-CHARACTERIZATION OF LYMPHOCYTES-T PROPAGATED FROM HUMAN-LUNG CARCINOMAS [J].
KURNICK, JT ;
KRADIN, RL ;
BLUMBERG, R ;
SCHNEEBERGER, EE ;
BOYLE, LA .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1986, 38 (03) :367-380
[10]  
LEIBOVITZ A, 1976, CANCER RES, V36, P4562